Claudia Cavelti-Weder

Has grant

Leitende Ärztin (chief of service)

University Hospital of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Claudia Cavelti-Weder is a Chief of Service at the University Hospital of Zurich, Switzerland. Her research focuses on diabetes management, metabolic diseases, and the impact of bariatric surgery on reproductive health. Recent publications include studies on diabetes knowledge questionnaires, advanced hybrid closed loop systems for diabetes, and the effects of air pollution on metabolic health.

Recent Grants

Grant: Close

Swiss Multicenter Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM)

Open Date: 2022-03-01

Close Date: 2026-02-28

Grant: Close

Swiss Multicentre Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM)

Open Date: 2022-01-01

Close Date: 2025-12-01

Grant: Close

Comprehensive analysis of intestinal gut homeostasis before and after weight loss surgery

Open Date: 2022-01-01

Close Date: 2023-12-01

Grant: Close

Swiss Multicentre Randomized Controlled Trial on different Limb Lengths in Gastric Bypass Surgery (SLIM)

Open Date: 2022-01-01

Close Date: 2024-12-01

Grant: Close

Air pollution-induced diabetes: Mechanistic role of intestinal macrophages in mice and humans

Open Date: 2021-01-01

Close Date: 2023-12-01

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (15)

Stephanie Christine Ganal-Vonarburg

Assistant Professor

University of Bern

SWITZERLAND

Claudia Cavelti-Weder

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Development and validation of a diabetes/nutrition knowledge questionnaire in type 1 and type 2 diabetes

Real-world evidence supporting the use of advanced hybrid closed loop in poorly controlled type 1 diabetes patients

Family planning, reproductive health and pregnancy after bariatric surgery: a survey of bariatric healthcare professionals in Switzerland

CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice

Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases

Diesel Exhaust Particle (DEP)-induced glucose intolerance is driven by an intestinal innate immune response and NLRP3 activation in mice.

Lung versus gut exposure to air pollution particles differentially affect metabolic health in mice.

Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity

Roux-en-Y gastric bypass with a long versus a short biliopancreatic limb improves weight loss and glycemic control in obese mice

Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity.

Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial

Liver, NAFLD and COVID-19.

Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation

Collaborators (15)

Stephanie Christine Ganal-Vonarburg

Christian U. Riedel

Eduardo Villablanca

Nerea Fernandez Trigo

Jan Niess

Matthias Hepprich

Daniel Konrad

Melanie Greter

Rodrigo Alonso Morales Castro

Anne Wojtusciszyn

Pascale Vonaesch

Prisca Liberali

Philipp A Gerber

Maria L. Balmer

Petr Hruz

Make your next move.